Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
2.
J Med Syst ; 46(7): 50, 2022 Jun 08.
Article in English | MEDLINE | ID: mdl-35674989

ABSTRACT

BACKGROUND: Electronic Health Records (EHRs) can help clinicians to plan, document and deliver care for patients in healthcare services. When used consistently, EHRs can advance patient safety and quality, and reduce clinician's workload. However, usability problems can make it difficult for clinicians to use EHRs effectively, which can negatively impact both healthcare professionals and patients. OBJECTIVE: To improve usability of EHRs within a mental health service in the UK. METHODS: This was a feasibility study conducted with two mental health teams. A mixed-methods approach was employed. Focus group discussions with clinicians identified existing usability problems in EHRs and changes were made to address these problems. Updated EHR assessment forms were evaluated by comparing the following measures pre and post changes: (1) usability testing to monitor time spent completing and duplicating patient information in EHRs, (2) clinician's experience of using EHRs, and (3) proportion of completed EHR assessment forms. RESULTS: Usability testing with clinicians (n = 3) showed that the time taken to complete EHR assessment forms and time spent duplicating patient information decreased. Clinician's experience of completing EHR assessment forms also significantly improved post changes compared to baseline (n = 71; p < 0.005). There was a significant increase in completion of most EHR forms by both teams after EHR usability improvements (all at p < 0.01). CONCLUSIONS: Usability improvements to EHRs can reduce the time taken to complete forms, advance clinician's experience and increase usage of EHRs. It is important to engage healthcare professionals in the usability improvement process of EHRs in mental health services.


Subject(s)
Electronic Health Records , Mental Health , Feasibility Studies , Humans , Patient Safety , United Kingdom
3.
Molecules ; 25(2)2020 Jan 10.
Article in English | MEDLINE | ID: mdl-31936861

ABSTRACT

In our current work, we have reported the first cobalt-catalyzed cross-coupling of arylboronic acid with alkyl/aryl phosphites under mild conditions. The reaction was carried out in the presence of zinc powder as an additive and ter-pyridine as a ligand. The use of non-precious cobalt salt makes the protocol advantageous, as it is inexpensive and more abundant than the previously used methods where precious metal salts (Pd and Pt) were used. The reaction has a wide substrate scope and the products were obtained in good yields.


Subject(s)
Boronic Acids/chemistry , Cobalt/chemistry , Zinc/chemistry , Catalysis
4.
J Pharm Sci ; 103(2): 527-38, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24375069

ABSTRACT

The impact of filler-lubricant particle size ratio variation (3.4-41.6) on the attributes of an immediate-release tablet was compared with the impacts of the manufacturing method used (direct compression or dry granulation) and drug loading (1%, 5%, and 25%), particle size (D[4,3]: 8-114 µm), and drug type (theophylline or ibuprofen). All batches were successfully manufactured, except for direct compression of 25% drug loading of 8 µm (D[4,3]) drug, which exhibited very poor flow properties. All manufactured tablets possessed adequate quality attributes: tablet weight uniformity <4% RSD, tablet potency: 94%-105%, content uniformity <6% RSD, acceptance value ≤ 15, solid fraction: 0.82-0.86, tensile strength >1 MPa, friability ≤ 0.2% weight loss, and disintegration time < 4 min. The filler-lubricant particle size ratio exhibited the greatest impact on blend and granulation particle size and granulation flow, whereas drug property variation dominated blend flow, ribbon solid fraction, and tablet quality attributes. Although statistically significant effects were observed, the results of this study suggest that the manufacturability and performance of this immediate-release tablet formulation is robust to a broad range of variation in drug properties, both within-grade and extra-grade excipient particle size variations, and the choice of manufacturing method.


Subject(s)
Chemistry, Pharmaceutical/methods , Drug Compounding/methods , Excipients/analysis , Tablets/analysis , Carboxymethylcellulose Sodium/analysis , Cellulose , Chemistry, Pharmaceutical/standards , Drug Compounding/standards , Excipients/standards , Hardness , Ibuprofen/administration & dosage , Ibuprofen/analysis , Lactose , Lubricants , Particle Size , Powders , Pressure , Solubility , Stearic Acids/analysis , Tablets/standards , Theophylline/administration & dosage , Theophylline/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...